MPI is a Danish pharmacodiagnostic company with proprietary pivotal technology (DNA microarray, qPCR based) which is Universally Applicable to any drug and any disease to determine Drug Reponse Prediction (DRP).
DRUG TARGETING
|
PHARMACO Dx
|
- Speed up Drug Development
- Save millions on development cost
- Increase drug development success
- Maximize on-patent sales period
|
|
DNA MICROARRAY SERVICES
For your gene / drug discovery needs MPI offers highest quality, bioinformatics expertise, turn-around time and cost-effectiveness for your research projects.
|
|
Announcements
MPI offers workshop in Drug Targeting
On November 30, 2009,... Read more Blind clinical validation of drug response predictor
... Read more Affymetrix and MPI Collaborate to Develop Cancer Treatment Products... Read more
|